Observational evidence that urbanisation and neighbourhood deprivation are associated with escalation in chronic pharmacological pain treatment: a longitudinal population-based study in the Netherlands.

Carsten Leue, Servaas Buijs, Jacqueline Strik, Richel Lousberg, Jasper Smit, Maarten van Kleef, Jim van Os
Author Information
  1. Carsten Leue: Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands.

Abstract

OBJECTIVE: To examine, in the light of the association between urban environment and poor mental health, whether urbanisation and neighbourhood deprivation are associated with analgesic escalation in chronic pharmacological pain treatment and whether escalation is associated with prescriptions of psychotropic medication.
DESIGN: Longitudinal analysis of a population-based routine dispensing database in the Netherlands.
SETTING: Representative sample of pharmacies, covering 73% of the Dutch nationwide medication consumption in the primary care and hospital outpatient settings.
PARTICIPANTS: 449 410 patients aged 15-85 years were included, of whom 166 374 were in the Starter group and 283 036 in the Continuation group of chronic analgesic treatment.
MAIN OUTCOME MEASURE: Escalation of analgesics (ie, change to a higher level of analgesic potency, classified across five levels) in association with urbanisation (five levels) and dichotomous neighbourhood deprivation was analysed over a 6-month observation period.
METHODS: Ordered logistic multivariate model evaluating analgesic treatment.
RESULTS: In both Starter and Continuation groups, escalation was positively associated with urbanisation in a dose-response fashion (Starter group: OR (urbanisation level 1 compared with level 5): 1.24, 95% CI 1.18 to 1.30; Continuation group: OR 1.18, 95% CI 1.14 to 1.23). An additional association was apparent with neighbourhood deprivation (Starter group: OR 1.07, 95% CI 1.02 to 1.11; Continuation group: OR 1.04, 95% CI 1.01 to 1.08). Use of somatic and particularly psychotropic co-medication was associated with escalation in both groups.
CONCLUSIONS: Escalation of chronic analgesic treatment is associated with urban and deprived environments and occurs in a context of adding psychotropic medication prescriptions. These findings suggest that pain outcomes and mental health outcomes share factors that increase risk and remedy suffering.

References

  1. Anesthesiology. 2006 Mar;104(3):570-87 [PMID: 16508405]
  2. J Neurosci. 2011 Aug 31;31(35):12491-500 [PMID: 21880911]
  3. Pain Pract. 2006 Jun;6(2):112-8 [PMID: 17309719]
  4. Soc Sci Med. 2011 Jun;72(12):1993-2002 [PMID: 21632160]
  5. Nature. 2011 Jun 22;474(7352):498-501 [PMID: 21697947]
  6. J Psychosom Res. 2010 Mar;68(3):295-302 [PMID: 20159217]
  7. Clin J Pain. 2009 Jul-Aug;25(6):461-8 [PMID: 19542792]
  8. Pain. 2000 Jan;84(1):95-103 [PMID: 10601677]
  9. Ann Epidemiol. 2011 Apr;21(4):231-7 [PMID: 21376269]
  10. Gut. 2009 Mar;58(3):367-78 [PMID: 19001059]
  11. Soc Sci Med. 2007 Jan;64(1):21-34 [PMID: 17011689]
  12. Br J Psychiatry. 2006 Aug;189:109-17 [PMID: 16880479]
  13. J Bone Joint Surg Am. 2011 Mar 16;93(6):556-63 [PMID: 21411706]
  14. Psychother Psychosom. 2000 May-Jun;69(3):147-54 [PMID: 10773779]
  15. Am J Med. 1997 Nov;103(5):339-47 [PMID: 9375700]
  16. Arch Gen Psychiatry. 2005 Aug;62(8):903-10 [PMID: 16061768]
  17. Arch Gen Psychiatry. 2001 Jul;58(7):663-8 [PMID: 11448373]
  18. Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004844 [PMID: 18843669]
  19. Psychosom Med. 2002 Sep-Oct;64(5):773-86 [PMID: 12271108]
  20. J Clin Pharm Ther. 2008 Feb;33(1):17-23 [PMID: 18211612]
  21. Science. 2006 Feb 10;311(5762):864-8 [PMID: 16469931]
  22. Rheumatol Int. 2013 Mar;33(3):587-92 [PMID: 22476243]
  23. Can Fam Physician. 2010 Jun;56(6):514-7, e202-5 [PMID: 20547511]
  24. Pain Physician. 2011 Mar-Apr;14(2):E217-45 [PMID: 21412381]
  25. Am J Ther. 2010 Sep-Oct;17(5):498-510 [PMID: 20844348]
  26. Pain Med. 2007 Sep;8 Suppl 2:S75-82 [PMID: 17714118]
  27. Gastroenterology. 2006 Apr;130(5):1447-58 [PMID: 16678558]
  28. Am J Med. 2010 Aug;123(8):675-82 [PMID: 20541169]
  29. Soc Psychiatry Psychiatr Epidemiol. 2003 Dec;38(12):698-706 [PMID: 14689174]
  30. Brain. 2010 Jul;133(Pt 7):2098-114 [PMID: 20558415]
  31. Acta Psychiatr Scand. 2010 Feb;121(2):84-93 [PMID: 19624573]
  32. J Clin Psychiatry. 2006 Aug;67(8):1219-25 [PMID: 16965199]
  33. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454 [PMID: 17943857]
  34. Osteoporos Int. 2011 May;22(5):1537-46 [PMID: 20838773]
  35. Psychosomatics. 2008 May-Jun;49(3):191-8 [PMID: 18448772]
  36. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007938 [PMID: 21412914]
  37. J Psychosom Res. 2004 Apr;56(4):413-8 [PMID: 15094025]
  38. Med Clin North Am. 2006 Jul;90(4):679-92 [PMID: 16843768]
  39. Neuroimage. 2009 Sep;47(3):995-1001 [PMID: 19375508]
  40. Br J Psychiatry. 2007 Dec;191:500-5 [PMID: 18055953]
  41. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007076 [PMID: 19588419]
  42. Biol Psychiatry. 2011 Dec 1;70(11):1033-8 [PMID: 21855859]
  43. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD007503 [PMID: 20238354]
  44. Lancet Neurol. 2011 May;10(5):446-56 [PMID: 21511198]
  45. JAMA. 2011 Apr 6;305(13):1315-21 [PMID: 21467284]
  46. Br J Psychiatry. 1998 Sep;173:255-61 [PMID: 9926103]
  47. JAMA. 2012 Mar 7;307(9):940-7 [PMID: 22396516]
  48. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006044 [PMID: 21328280]
  49. Epidemiol Rev. 2008;30:84-100 [PMID: 18669521]
  50. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005451 [PMID: 21249671]
  51. JAMA. 2009 Jan 14;301(2):198-209 [PMID: 19141768]

Word Cloud

Created with Highcharts 10.0.01associatedurbanisationanalgesicescalationneighbourhooddeprivationchronictreatmentStarterContinuationgroup:OR95%CIassociationpainpsychotropicmedicationlevelurbanmentalhealthwhetherpharmacologicalprescriptionspopulation-basedNetherlandsgroupEscalationfivelevelsgroups18outcomesOBJECTIVE:examinelightenvironmentpoorDESIGN:LongitudinalanalysisroutinedispensingdatabaseSETTING:Representativesamplepharmaciescovering73%DutchnationwideconsumptionprimarycarehospitaloutpatientsettingsPARTICIPANTS:449 410patientsaged15-85yearsincluded166 374283 036MAINOUTCOMEMEASURE:analgesicsiechangehigherpotencyclassifiedacrossdichotomousanalysed6-monthobservationperiodMETHODS:OrderedlogisticmultivariatemodelevaluatingRESULTS:positivelydose-responsefashioncompared5:24301423additionalapparent070211040108Usesomaticparticularlyco-medicationCONCLUSIONS:deprivedenvironmentsoccurscontextaddingfindingssuggestsharefactorsincreaseriskremedysufferingObservationalevidencetreatment:longitudinalstudy

Similar Articles

Cited By